Acquired dysfunction due to the circulation of "exhausted" platelets

Area of Science:

• Hematology
• Immunology
• Nephrology

Background:

• Acquired platelet functional defects can arise in patients with diverse clinical conditions.
• Understanding these defects is crucial for managing bleeding risks.

Observation:

• Eight patients with renal allograft rejection, hemolytic uremic syndrome/thrombotic thrombocytopenic purpura, transfusion-related coagulopathy, or systemic lupus erythematosus exhibited acquired platelet dysfunction.
• Key observations included defective platelet aggregation, reduced adenine nucleotides and serotonin, and impaired amine uptake/storage.

Findings:

• The acquired platelet defect presented with prolonged bleeding times disproportionate to platelet counts.
• These abnormalities closely resembled those seen in congenital storage pool deficiency.
• The defect is hypothesized to result from in vivo platelet 'exhaustion' due to exposure to release-inducing agents like thrombin and immune complexes.

Implications:

• This acquired platelet dysfunction may exacerbate bleeding in patients with severe underlying conditions.
• Identifying and understanding acquired platelet defects is vital for improving patient outcomes and therapeutic strategies.